Smith & Nephew PLC
LSE:SN

Watchlist Manager
Smith & Nephew PLC Logo
Smith & Nephew PLC
LSE:SN
Watchlist
Price: 1 071 GBX 0.37% Market Closed
Market Cap: 9.4B GBX
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one SN stock under the Base Case scenario is 1 765.33 GBX. Compared to the current market price of 1 071 GBX, Smith & Nephew PLC is Undervalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SN Relative Value
Base Case
1 765.33 GBX
Undervaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.1
P/S
P/S
Price to Sales
2.1
vs History
76
vs Industry
46
Median 3Y
2.2
Median 5Y
2.5
Industry
2.2
Forward
0
More Details
29.4
P/E
P/E
Price to Earnings
29.4
vs History
63
vs Industry
19
Median 3Y
41.5
Median 5Y
36.4
Industry
22.5
Forward
0.3
More Details
12.3
P/OCF
P/OCF
Price to OCF
12.3
vs History
88
vs Industry
30
Median 3Y
18
Median 5Y
17.5
Industry
13.9
More Details
16.6
P/FCFE
P/FCFE
Price to FCFE
16.6
vs History
47
vs Industry
25
Median 3Y
17.7
Median 5Y
16
Industry
19.7
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
63
vs Industry
36
Median 3Y
2.2
Median 5Y
2.5
Industry
2.1
More Details
47.5
EV/S
EV/S
Enterprise Value to Sales
47.5
vs History
39
vs Industry
4
Median 3Y
47.5
Median 5Y
46.6
Industry
2.3
Forward
0.4
More Details
67.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
67.7
vs History
31
vs Industry
3
Median 3Y
67.2
Median 5Y
65.6
Industry
4.9
More Details
179.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
179.9
vs History
47
vs Industry
1
Median 3Y
186
Median 5Y
179.3
Industry
11.9
Forward
1.7
More Details
310.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
310.4
vs History
68
vs Industry
1
Median 3Y
346.3
Median 5Y
345.4
Industry
16.4
Forward
2.6
More Details
279.8
EV/OCF
EV/OCF
Enterprise Value to OCF
279.8
vs History
57
vs Industry
1
Median 3Y
401.6
Median 5Y
292.4
Industry
13.7
More Details
455.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
455.8
vs History
57
vs Industry
1
Median 3Y
1 052.9
Median 5Y
665.7
Industry
17.2
More Details
32.1
EV/IC
EV/IC
Enterprise Value to IC
32.1
vs History
20
vs Industry
2
Median 3Y
29.2
Median 5Y
28.2
Industry
1.8
More Details

Multiples Across Competitors

SN Competitors Multiples
Smith & Nephew PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Smith & Nephew PLC
LSE:SN
9.4B GBP 2.1 29.4 179.9 310.4
US
Abbott Laboratories
NYSE:ABT
226.5B USD 5.4 16.9 22.6 33.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
175.2B USD 21 75.4 58.4 70.8
US
Boston Scientific Corp
NYSE:BSX
146.4B USD 8.7 79 36.1 51
US
Stryker Corp
NYSE:SYK
139B USD 6.2 46.4 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
112.5B USD 3.4 26.4 14.1 19.9
US
Becton Dickinson and Co
NYSE:BDX
66B USD 3.2 37.7 15.7 28.3
DE
Siemens Healthineers AG
XETRA:SHL
56.7B EUR 2.5 28.6 16.3 23.3
US
Edwards Lifesciences Corp
NYSE:EW
41.7B USD 7.7 10 23.5 25.9
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
288.7B CNY 7.8 23.3 20.4 20.4
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
36.6B USD 1.9 18.3 12.8 15.7

See Also

Summary
SN intrinsic value, competitors valuation, and company profile.
DCF Valuation
SN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SN stock valuation using valuation multiples.
Wall Street Estimates
SN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 242,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.